18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
about
18F PET ligands for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images.Validation of 18F-FDG-PET Single-Subject Optimized SPM Procedure with Different PET Scanners.CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).The emerging role of PET imaging in dementia.Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer's disease.Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer's disease.Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.Classification of Alzheimer's and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET.Are methodological quality and completeness of reporting associated with citation-based measures of publication impact? A secondary analysis of a systematic review of dementia biomarker studies.Molecular biomarkers of Alzheimer's disease: progress and prospects.Cerebral glucose metabolic prediction from amnestic mild cognitive impairment to Alzheimer's dementia: a meta-analysis.A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease.Validity of the QUADAS-2 in Assessing Risk of Bias in Alzheimer's Disease Diagnostic Accuracy Studies.
P2860
Q26472008-EFD0D60A-610B-4883-9B77-28CDCEB7E6A7Q31153910-2D9DABCF-D40B-43AF-84E9-752EBC386CCBQ33701135-925EB043-F96C-4DFB-B58B-C93EF80E5AADQ36243629-D0579C9E-8AF5-4548-8FA0-4820BAEC20EEQ38741683-5A5FB822-C311-42E9-9276-135CCD25750CQ42701971-60443551-F844-4070-958A-18092D6C5EF5Q46133238-5AECEAD5-156E-441D-983D-8877A0C2E327Q47200597-82162D96-2149-42FC-8A99-AD1707E8981BQ47209544-D67892BE-862B-4806-B01D-57E49B180392Q47209556-AC0BE8F2-DB9F-4C5A-8C9F-AF743E7CED12Q47209563-74BFCBA0-6EE7-4BFB-B65E-D1476D2EED34Q47553874-9019E43C-6763-4DD2-8C92-BF94C7C837ACQ47697345-571EA1FA-1C98-4671-B057-FE9D5C008682Q48799327-8466236D-C32B-4D77-B9A5-68D393DF2A5DQ53396334-1C6F5ADD-1D32-4373-A334-AC7701D786DBQ53819680-23CF8AE6-BEA1-4108-85B4-594F00F1295EQ53835370-3096A6D9-E13F-4C43-BC82-DE51FC2E0334Q54946040-33F66F2C-E574-4A98-BE9B-0D3560EC6EC0Q54961676-63300884-D95E-46F6-AC18-AF1BB04A42CEQ54980020-93B9567A-CB2D-4F3E-92B9-ED033979CA94Q55025120-816B2D47-6A4B-453D-8A86-96E7E5154269
P2860
18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@ast
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@en
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@en-gb
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@nl
type
label
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@ast
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@en
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@en-gb
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@nl
prefLabel
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@ast
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@en
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@en-gb
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@nl
P2093
P2860
P1476
18 F-FDG PET for the early dia ...... ild cognitive impairment (MCI)
@en
P2093
Chris Hyde
Christos Sachpekidis
Nadja Smailagic
Obioha Ukoumunne
Steven Martin
P2860
P304
P356
10.1002/14651858.CD010632.PUB2
P577
2015-01-28T00:00:00Z